Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 23, 2019Journal of Child NeurologyOpen Access

The Clinical Journey of Patients with Riboflavin Transporter Deficiency Type 2

View Full Paper
Ask AI
Bookmark
Share

Authors

FAFatima AmirCACarrie AtzingerKMKeith Massey

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Amir et al. (2019) studied this question.

synapsesocial.com/papers/6aab61ffbf7e65667fc59603https://doi.org/10.1177/0883073819893159
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Brown‐Vialetto‐Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment2010 · 240 citations
  2. 2Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease2012 · 139 citations
  3. 3The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives2012 · 147 citations